Normal and aberrant splicing of LMNA

Area of Science:

• Molecular Biology
• Genetics
• Cell Biology

Background:

• The LMNA gene produces multiple isoforms, including lamin A and C, crucial for nuclear lamina structure and function.
• LMNA mutations lead to a wide range of diseases known as laminopathies, affecting various tissues and presenting diverse clinical phenotypes.
• Alternative splicing of LMNA is tightly regulated and critical for producing functional protein isoforms.

Purpose of the Study:

• To review the alternatively spliced isoforms of the LMNA gene.
• To discuss the regulatory mechanisms governing LMNA splicing.
• To connect aberrant LMNA splicing to clinical phenotypes and explore therapeutic interventions.

Main Methods:

• Literature review of LMNA gene splicing, regulation, and associated diseases.
• Analysis of the relationship between pre-mRNA mis-splicing and clinical manifestations.
• Discussion of splice-switching antisense oligonucleotides as a therapeutic approach.

Main Results:

• LMNA splicing is complex, involving multiple regulatory factors and untranslated regions.
• Specific LMNA mutations can disrupt normal splicing, leading to transcript-level abnormalities.
• A strong correlation exists between mis-spliced LMNA transcripts and the development of laminopathies.

Conclusions:

• Understanding LMNA splicing is key to comprehending the pathogenesis of laminopathies.
• Targeting LMNA splicing with splice-switching antisense oligonucleotides shows therapeutic promise for treating certain laminopathies.